New medMATCH® Report Resources

Our enhanced medMATCH® report provides actionable insights and “at-a-glance” interpretation. Below you’ll find resources highlighting the features of the report, information about our test panels and recent test code changes, and an explanation of our simplified ordering process.

Walk through the new report features with our interactive PDF

Walk through the new report features with our interactive PDF

Download
Test Code Crosswalk

Test Code Crosswalk

Download
Report Redesign Customer Announcement Letter

Report Redesign Customer Announcement Letter

Download
Clinical Drug Monitoring Test List and Panels

Clinical Drug Monitoring Test List and Panels

Download

At-Home / Self-Collection Resources

The following resources are provided to assist patients in completing at-home or self-collection of lab samples for physician-ordered drug monitoring tests. The resources include an instruction guide and demonstration video for oral fluid self-collection, and an instruction guide for urine specimen self-collection.

Oral-Eze

Video: A demonstration of Oral Fluid Sample Collections with Oral-Eze®

View

Oral Fluid At-Home Collection Guide

Download

Oral Fluid At-Home Collection Guide (Spanish Version)

Download

Urine Specimen At-Home Collection Guide

Download

At-Home Collection Patient Letter

Download

COVID-19 Resources

The COVID-19 pandemic presents some difficult challenges to providing appropriate levels of drug monitoring for opioids and other prescription drugs. Below are some resources we hope will be helpful.

SAMHSA Resource Guide: Treating patients during COVID-19

Download

AAPM COVID-19 Best Practice Guidelines

Download

Brochure: Quest Patient Service Centers can help when in-office testing is not an option

Download

Video: Telemedicine: Prescribing during the COVID-19 pandemic

View

Video: Medications Adherence: Challenges during the COVID-19 pandemic

View

Video: Increased Drug Misuse during the COVID-19 pandemic

View

Clinical Conversation: Drug Monitoring & Patient Care during the COVID-19 pandemic

Read

Now Available: 2020 Health Trends™ study

To better understand the relationship between the COVID-19 pandemic and the drug misuse epidemic in the US, Quest Diagnostics study investigators analyzed changes in drug positivity rates and drug testing volumes, utilizing deidentified urine drug testing (UDT) results from January 1, 2019 to May 16, 2020.

Study results show that prescription drug monitoring declined during the weeks of the COVID-19 pandemic studied, while positivity for nonprescribed illicit drugs and dangerous drug combinations increased.

The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020, published in Population Health Management

Read

Health Trends 2020 Article Summary & Infographic

Download

Health Trends™: Drug Misuse in America 2019

Drug Misuse in America 2019: Physician Perspectives and Diagnostic Insights on the Evolving Drug Crisis, a Quest Diagnostics Health Trends™ report, presents findings from analysis of more than 4.4 million de-identified aggregated clinical drug monitoring tests performed by Quest Diagnostics for patients from all 50 states and District of Columbia from 2011 through 2018.

A collaboration between the Center on Addiction and Quest Diagnostics, this report may be the first of its kind, juxtaposing an analysis of more than 4.4 million de-identified clinical drug monitoring tests by Quest Diagnostics and a survey conducted by The Harris Poll of 500 primary care physicians about their patients’ use of controlled substances.

2019 Quest Diagnostics Health Trends Report

Download

2019 Health Trends Infographic: Insights on the evolving drug crisis

Download

2019 Health Trends Infographic: Insights on HCP perceptions of the evolving drug crisis

Download

Industry, product, and services information

As an industry leader in drug testing, Quest Diagnostics provides a wealth of information and resources to help you make more informed decisions for your patients.

Drug monitoring reference guide

Download

Video – Why Every Clinician Needs to Integrate Drug Monitoring into their Practice with Jeff Gudin, MD

View

Video - How to Set the Stage for a Drug Monitoring Program with your Patient with Jeff Gudin, MD

View

Video - How to Share Drug Monitoring Results with Your Patient with Jeff Gudin, MD

View

ICD-10 resource brochure

Download

Medication misuse infographic

Download

Oral-Eze fluid collection guide

Download

Oral fluid drug testing brochure

Download

Drug monitoring for behavioral health services brochure

Download

Drug disposal poster

Download

Drug monitoring for hospitals brochure

Download

Drug monitoring for clinicians brochure

Download

Drug monitoring protocol monograph

Download

Case Study: Testing for Methamphetamines

Download

Webinar Library

​Browse our webinar library for a series of presentations by leading medical experts at Quest Diagnostics.

True or False? Presumptive Drug Testing
F. Leland McClure, MSc, PhD, F-ABFT
 Director, Medical Science Liaison, Medical Affairs
 Quest Diagnostics
Interpreting Opiates Drug Testing
F. Leland McClure, MSc, PhD, F-ABFT
 Director, Medical Science Liaison, Medical Affairs
 Quest Diagnostics
Poppy Seeds and Interpreting Opiates Drug Testing
F. Leland McClure, MSc, PhD, F-ABFT
 Director, Medical Science Liaison, Medical Affairs
 Quest Diagnostics